[#item_full_content] Recently, President Donald Trump signed an executive order reclassifying cannabis as a Schedule 3 drug in the U.S., easing access to banking and enabling standard tax deductions for cannabis businesses. This regulatory shift materially improves the operating landscape for companies like Tilray Brands, potentially accelerating their ability to leverage existing hemp operations to expand into the U.S. market. Next, we’ll examine how easier banking access under Schedule 3 could reshape Tilray… Read More
PSN Briefings
Plain-English cannabis industry updates — what changed, what didn’t, and why it matters.
Episode 1 • Federal Rescheduling — What Actually ChangedLatest PSN Briefs
Short, plain-English updates from the PSN desk
- What federal rescheduling did NOT change
- Why state cannabis boards still control outcomes
- What operators should not assume in 2026